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LETTERS TO THE EDITOR 
IgA Class Antibodies in Dermatitis Herpetiformis: Reaction 
with Tissue Antigens 
To the Editor: 
In an extensive study ..Published in the August 1989 issue of the 
Journal, Kadunce et all1] were not able to dem~nstr.ate specific sites 
in normal human skin to which IgA class anttbodtes from sera of 
patients with dermatitis herpetiformis (DH) bind. They wondered 
if such binding sites were unique to the skm of DH pattents. . 
We recently conducted indirect immunofluor~scence studtes 
(standard techniques and with _prolonged mcubat10n) usmg s~ra 
from a patient suffenng from acttve, htstologtcally ~nd tmmunohts-
tologically proved DH (antigliadin IgA class anttbodtes < 1.: 20, 
antiendomysial IgA class antibodies positive) and from two pattents 
with coeliac disease (antigliadin IgA class antlbodtes 1 : 320 and 
1: 640). 
Circulating IgA-C3 immune complexes were assessed by enzyme 
immunoassay: all three sera had varying amounts of material cap-
tured by mouse monoclonal anti-C3dg antibodies and detected. by 
biotinylated monoclonal antihuman IgA anttbodtes. H~wever, tf a 
mouse monoclonal ant ibody of the same subclass as antt-C3dg but 
with unknown specifity was coated, all sera showed positive reac-
tions again. This phenomenon was also demonstrated w1th further 
five DH and four coeliac disease sera. Only 111 two coe!tac dtsease 
sera was the difference of the optical density high enough to suggest 
real presence of circulating IgA-C3- containing immune com-
plexes. One of them was used in our experiments. 
Apart from normal skin, non-lesional skin samples from two 
patients with DH were included in the immunofluorescence exper-
iments. One of them was obtained from the donor of the above-
mentioned DH serum. Compared to the weak granular staining 
below the dermal-epidermal junction zone of the D H skin in direct 
immunofluorescence, no additional binding of IgA or C3 was de-
tected even after prolonged incubation of the DH skin with the 
three sera. 
Thus, extending the results ofKadunce et alto DH skin samples, 
deposi tion of IgA class antibodies in DH might rather depend on 
conditions such as the local state of the vascular bed or charge-
charge interactions at the dermal-epidermal junction zone [2] than 
on the presence of specific antigenic binding sites. Furthermore, 
doubts persist about the abi lity of IgA to mediate complement acti-
vation and to form complement-bearing immune complexes [3]. 
Therefore, the immunopathology of conditions such as DH may 
not be due to complement fixation by IgA immune complexes, and, 
as presented here, the data concerning circl~lating IgA immune 
complexes in DH sera shou ld be re-evaluated 111 vtew of methode-
logic problems of their detection. 
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REPLY 
We would like to thank Dr. Rast eta! for their comments regarding 
our paper. It appears that Rast et al have an assay th~t non-specifi-
cally detects circulating immune c~mplexes. By the1~ own adnus-
sion their mouse monoclonal antibody 1s non-spec1fic. Further-mer~ the sma ll number of sera they screened do not appear to bind 
IgA-bearing immune complexes to normal human skin. We did not 
attempt to assay IgA-class circulating 1.mmune complexes 111 the 
serum from our patients with dennatt.tts herpet~formts, but pnor 
work by Zone et al characterized IgA CJrculattng 1mmune complex 
levels in our population of DH patients [1] . Althoug.h we dtd not 
specifically screen for circulating immune complexes 111 our 6~ DH 
sera, varying levels of circu lating immune complexes were hkely 
present. Inference from our data, as well. as that ofl~.ast et al, does not 
support the speculation that IgA-classCJrculatmg 1mmune c.omplex 
deposition is active in the pathogenesis of dermatitis herpetlformts . 
The author's own data demonstrating h1gher levels of CJrculatmg 
immune complexes in patients with celiac disease, but without der-
matitis herpetiformis, would also speak agamst the role ~f circu lat-
ing immune complexes in dermatitiS herpettfonms. Fmally, not 
only have IgA aggregates been shown to activate com~lement, but a 
recent paper by Hendrix et al suggests that neutroph1ls are able to 
adhere to such IgA aggregates [2]. 
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